StemBioSys, Inc. is a privately held biomedical company in San Antonio, Texas. Our technologies represent the next evolution in cell research and are branded to the research market under the CELLvo™ label.
The centerpiece of these technologies is our platform CELLvo™ Matrix. This cell derived microenvironment allows a variety of cells to replicate more rapidly and express markers indicative of potency beyond that seen with traditional tissue culture substrates. This results in a more biologically relevant testing environment allowing for faster, more accurate and less expensive translation of research and therapeutic technologies. The company also has several cell products isolated and expanded on our matrix.
Most recently, StemBioSys has been developing a novel approach for new drug preclinical safety testing. By preparing a more natural in vitro microenvironment we have been able to develop model systems that more accurately depict human in vivo systems.